Interv Akut Kardiol. 2009;8(2):74-80

Haemodynamic (catheterization) diagnostics of diastolic dysfunction and diastolic failure

Jiří Endrys
I. interní klinika Fakultní nemocnice v Hradci Králové

Prevalence of diastolic heart failure may be as high as 30–50 % of all heart failures especially in elderly. Modern non-invasive methods

are routinely used for diagnosis of diastolic dysfunction. Causes of diastolic dysfunction are quite heterogeneous and present article

has to show diagnostic potentialities in hands of catheterizing cardiologist, who is able in some pathologies to intervene therapeutically.

In comparison to non-invasive methods catheterization can provide histological diagnosis by endomyocardial biopsy and perhaps

the optimal differentiation of restrictive cardiomyopathy from constrictive pericarditis.

Keywords: catheterization, diastolic dysfunction, diastolic heart failure, restrictive cardiomyopathy, constrictive pericarditis.

Published: May 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Endrys J. Haemodynamic (catheterization) diagnostics of diastolic dysfunction and diastolic failure. Interv Akut Kardiol. 2009;8(2):74-80.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kass DA, Midei M, Graves W, Brinker JA, Maughan WL. Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn 1988; 15: 192-202. Go to original source... Go to PubMed...
    2. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992; 117: 502-510. Go to original source... Go to PubMed...
    3. Chatterjee K. Primary diastolic heart failure. Am J Geriatr Cardiol 2002; 11: 178-187. Go to original source... Go to PubMed...
    4. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296: 2259-2260. Go to original source... Go to PubMed...
    5. Oh JK, Hatle L, Tajik AJ, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2008; 47: 500-506. Go to original source...
    6. Breen JF. Imaging of the pericardium. J Thorac Imaging 2001; 16: 47-54. Go to original source... Go to PubMed...
    7. Rathi VK, Doyle M, Yamrozik J, et al. Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach. J Cardiovasc Magn Reson 2008; 10: 36-44. Go to original source... Go to PubMed...
    8. Palacios IF, Tuzcu EM, Ziskind AA, et al. Percutaneous balloon pericardial window for patients with malignant pericardial effusions and tamponade. Cathet Cardiovasc Diagn 1991; 22: 244-249. Go to original source... Go to PubMed...
    9. Karam N, Patel P, deFilippi C. Diagnosis and management of chronic pericardial effusions. Am J Med Sci 2001; 322: 79-87. Go to original source... Go to PubMed...
    10. Gorlin R, Gorlin SG. Hydraulic formula for calculation of stenotic mitral valve, other cardiac valves and central circulatory shunts. Am Heart J 1951; 41: 1-29. Go to original source... Go to PubMed...
    11. Gjertsson P, Caidahl K, Farasati M, Odén A, Bech-Hanssen O. Preoperative moderate to severe diastolic dysfunction: a novel Doppler echocardiographic long-term prognostic factor in patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2005; 129: 890-896. Go to original source... Go to PubMed...
    12. Gjertsson P, Caidahl K, Bech-Hanssen O. Left ventricular diastolic dysfunction late after aortic valve replacement in patients with aortic stenosis. Am J Cardiol 2005; 96: 722-727. Go to original source... Go to PubMed...
    13. Lund O, Fl? C, Jensen FT, et al. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J 1997; 18: 1845-1847. Go to original source... Go to PubMed...
    14. Faber L, Seggewiss H, Gietzen FH, et al. Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol 2005; 94: 516-523. Go to original source... Go to PubMed...
    15. Nagueh SF, Lakkis NM, Middleton KJ, et al. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999; 99: 344-347. Go to original source... Go to PubMed...
    16. Jassal DS, Neilan TG, Fifer MA, et al. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy Eur Heart J 2006; 27: 1805-1810. Go to original source... Go to PubMed...
    17. Monteiro PF, Ommen SR, Gersh BJ, et al. Effects of surgical septal myectomy on left ventricular wall thickness and diastolic filling. Amer J Cardiol 2007; 100: 1776-1778. Go to original source... Go to PubMed...
    18. Talreja DR, Nishimura RA, Oh JK, Holmes DR. Constrictive pericarditis in the modern era. Novel criteria for diagnosis in the cardiac catheterization laboratory. J Am Coll Cardiol 2008; 51: 315-319. Go to original source... Go to PubMed...
    19. Hurrell DG, Nishimura RA, Higano ST, et al. Value of dynamic respiratory changes in left and right ventricular pressures for the diagnosis of constrictive pericarditis. Circulation 1996; 93: 2007-2013. Go to original source... Go to PubMed...
    20. Nishimura RA. Constrictive pericarditis in the modern era: a diagnostic dilema. Heart 2001; 86: 619-623. Go to original source... Go to PubMed...
    21. Chowdhury UK, Subramaniam GK, Kumar AS, et al. Pericardiectomy for constrictive pericarditis: a clinical, echocardiographic, and hemodynamic evaluation of two surgical techniques. Ann Thorac Surg 2006; 81: 529-530. Go to original source... Go to PubMed...
    22. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007; 28: 3076-3093. Go to original source... Go to PubMed...
    23. McAllister HA Jr. Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection. Tex Heart Inst J 1995; 22: 53-66.
    24. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation 2005; 112: 2047-2060. Go to original source... Go to PubMed...
    25. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005; 75: 241-247. Go to original source... Go to PubMed...
    26. Fiocchi F, Ricci C, Ligabue G, et al. Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease. Clin Imaging 2008; 32: 474-476. Go to original source... Go to PubMed...
    27. Chimenti C, Hamdani N, Boontje NM, et al. Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. Am J Patol 2008; 172: 1482-1490. Go to original source... Go to PubMed...
    28. Koskenvuo JW, Hartiala JJ, Nuutila P, et al. Twenty-fourmonth alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters. J Inherit Metab Dis 2008; 31: 432-441. Go to original source... Go to PubMed...
    29. Hughes DA, Elliott PM, Shah J, et al. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 2008; 94: 138-139. Go to original source... Go to PubMed...
    30. Kovacevic-Preradovic T, Zuber M, Jost CH, et al. Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy Eur J Echocardiogr. 2008; 9: 729-735. Go to original source... Go to PubMed...
    31. Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, Moraes CR. Surgery for endomyocardial fibrosis revisited. Eur J Cardiothor Surg 1999; 15: 309-312. Go to original source... Go to PubMed...
    32. Mocumbi AO, Daniel Sidi D, Vouhe P, Yacoub M. An innovative technique for the relief of right ventricular trabecular cavity obliteration in endomyocardial fibrosis. J Thorac Cardiovasc Surg 2007; 134: 1070-1072. Go to original source... Go to PubMed...
    33. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002; 105: 1503-508. Go to original source... Go to PubMed...
    34. Warner JG Jr, Metzger DC, Kitzman DW, Wesley DJ, Little WC. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33: 1567-1572. Go to original source... Go to PubMed...
    35. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985; 72: 853-864. Go to original source... Go to PubMed...
    36. Setaro JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990; 66: 981-986. Go to original source... Go to PubMed...
    37. Endrys J. Hodnocení chlopenních stenóz. Invazivní hemodynamické metody. Hradec Králové: Nucleus, 2005: 74-92.
    38. McKay RG, Safian RD, Lock JE, et al. Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative and percutaneous valvuloplasty studies. Circulation 1986; 74: 119-125. Go to original source... Go to PubMed...
    39. Cribier A, Savin T, Berland J, et al. Percutaneous transluminal balloon valvuloplasty in adult aortic stenosis: Report of 92 cases. J Am Coll Cardiol 1987; 9: 381-386. Go to original source... Go to PubMed...
    40. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004; 43: 698-703. Go to original source... Go to PubMed...
    41. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008; 29: 1463-1470. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.